ARTIFICIAL ANTIGEN PRESENTING CELLS AND METHODS OF USE

The present disclosure relates to artificial antigen presenting cells (aAPCs), in particular engineered erythroid cells and enucleated cells (e.g. enucleated erythroid cells and platelets), that are engineered to activate or suppress T cells. 本公开涉及人工抗原呈递细胞(aAPC)，特别是经工程化改造以激活或抑制T细胞的工程化红系细胞和去核细胞(例如去核红...

Full description

Saved in:
Bibliographic Details
Main Authors SALVAT REGINA SOPHIA, WICKHAM THOMAS JOSEPH, DOWDEN NATHAN J, CHEN TIFFANY FEN-YI, ELLOUL SIVAN
Format Patent
LanguageChinese
English
Published 25.09.2020
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates to artificial antigen presenting cells (aAPCs), in particular engineered erythroid cells and enucleated cells (e.g. enucleated erythroid cells and platelets), that are engineered to activate or suppress T cells. 本公开涉及人工抗原呈递细胞(aAPC)，特别是经工程化改造以激活或抑制T细胞的工程化红系细胞和去核细胞(例如去核红系细胞和血小板)。
Bibliography:Application Number: CN201880089344